search
Back to results

Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults

Primary Purpose

Sarcopenia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
High intensity aerobic exercise
Resistance exercise training
Combined
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Sarcopenia focused on measuring Exercise, Aging, Sarcopenia, Muscle function

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy
  • 18 to 30 years or 65 to 80 years old
  • Male and female

Exclusion Criteria:

  • Regular exercise program
  • Smoking
  • Metabolic disease (diabetes, cardiovascular disease, cancer, thyroid disorders)
  • Pregnancy
  • Inability to exercise
  • Overweight or obesity
  • Drugs known to impair metabolic function (statin, beta-blocker, anti-inflammatory)
  • Allergies to lidocaine

Sites / Locations

  • Mayo Clinic

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Experimental

Arm Label

Aerobic Exercise Training

Combined

Resistance Exercise Training

Arm Description

Participants will perform 12-weeks of high intensity aerobic training.

The combined group will have 12-weeks of no exercise followed by 12-weeks of combined aerobic and resistance exercise training. Assessments will be made at three time points: baseline, after 12-weeks of no training, and after 12-weeks of combined training.

Participants will perform 12-weeks of resistance exercise training.

Outcomes

Primary Outcome Measures

Skeletal muscle protein synthesis rate
The investigators will determine the rate of incorporation of stable isotope amino acid tracers in skeletal muscle proteins during several hours of rest. The measurement will be an average resting muscle protein synthesis rate (% new muscle protein per hour) and will be performed at baseline and following 12 weeks of exercise training.

Secondary Outcome Measures

Full Information

First Posted
September 28, 2011
Last Updated
August 7, 2017
Sponsor
Mayo Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT01477164
Brief Title
Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults
Official Title
Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
November 2011 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
March 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Muscle proteins accumulate damage during aging and leads to the loss of muscle mass and function in older people. Exercise can increase the making of new proteins and removal of older proteins, but it is not known if the effect changes with aging or type of exercise. The investigators will determine the ability for endurance, resistance, or a combination of exercise training to remove older-damaged proteins and make newer-functional muscle proteins in groups of younger and older people. The investigators will particularly study protein that are involved with energy production (mitochondrial proteins) and force production (contractile proteins). Hypothesis 1: Older people will have greater accumulation of damaged proteins than younger people. Hypothesis 2: Aerobic exercise will decrease the accumulation of damaged forms of contractile and mitochondrial proteins in younger and older people. Hypothesis 3: Resistance exercise will decrease the accumulation of damaged forms of contractile proteins in younger and older people.
Detailed Description
The loss of muscle mass and function with age leads to high social and economic costs. Lifestyle interventions that can help maintain muscle mass and function can be beneficial to improve health and decrease the costs associated with loss of independence in the elderly. Muscle proteins accumulate damage during aging, which is suggested to lead to loss of function. The biological processes that remove damaged proteins and synthesis new proteins appear to be decreased with aging. Exercise is known to increase the processes that remove older and synthesis newer muscle proteins and may be an effect lifestyle intervention to improve muscle quality and function. Additionally, specific types of proteins appear to decay with age including contractile and mitochondrial proteins. Different types of exercise training can increase the making of specific proteins. The investigators will examine the ability for aerobic and resistance training to increase the quality of mitochondrial and contractile proteins between younger and older people.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia
Keywords
Exercise, Aging, Sarcopenia, Muscle function

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
72 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aerobic Exercise Training
Arm Type
Experimental
Arm Description
Participants will perform 12-weeks of high intensity aerobic training.
Arm Title
Combined
Arm Type
Active Comparator
Arm Description
The combined group will have 12-weeks of no exercise followed by 12-weeks of combined aerobic and resistance exercise training. Assessments will be made at three time points: baseline, after 12-weeks of no training, and after 12-weeks of combined training.
Arm Title
Resistance Exercise Training
Arm Type
Experimental
Arm Description
Participants will perform 12-weeks of resistance exercise training.
Intervention Type
Behavioral
Intervention Name(s)
High intensity aerobic exercise
Intervention Description
Participants will perform 12-weeks of high intensity aerobic training. Training will be 5-days per week. Three days (e.g. Monday, Wednesday and Friday) will include repeated bouts of cycling for 4-minutes at ~90% maximal effort followed by 3 minutes of active rest. The other two days (e.g. Tuesday and Thursday) will be treadmill exercise for 45 minutes at 70% of maximal effort.
Intervention Type
Behavioral
Intervention Name(s)
Resistance exercise training
Intervention Description
Participants will perform 12-weeks of resistance exercise training. Training will be 5-days per week of daily sessions of 60 minutes that include resistance exercise for all major muscle groups.
Intervention Type
Behavioral
Intervention Name(s)
Combined
Intervention Description
The combined group will be assessed before and after 12 weeks of no exercise training, then again following 12 weeks of combined aerobic and resistance exercise training.
Primary Outcome Measure Information:
Title
Skeletal muscle protein synthesis rate
Description
The investigators will determine the rate of incorporation of stable isotope amino acid tracers in skeletal muscle proteins during several hours of rest. The measurement will be an average resting muscle protein synthesis rate (% new muscle protein per hour) and will be performed at baseline and following 12 weeks of exercise training.
Time Frame
Approximately 14 weeks for the endurance or resistance training groups and approximately 28 weeks for the combined group

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy 18 to 30 years or 65 to 80 years old Male and female Exclusion Criteria: Regular exercise program Smoking Metabolic disease (diabetes, cardiovascular disease, cancer, thyroid disorders) Pregnancy Inability to exercise Overweight or obesity Drugs known to impair metabolic function (statin, beta-blocker, anti-inflammatory) Allergies to lidocaine
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
K. Sreekumaran Nair, M.D., Ph.D.
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effects of Aerobic and Resistance Training on Accumulation of Old, Modified Proteins in Young and Older Adults

We'll reach out to this number within 24 hrs